Anti-UTS2B/ U2B/ URP functional antibody

Anti-UTS2B/ U2B/ URP functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to UTS2B/UTS2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0540-Ab-1/ GM-Tg-hg-SE0540-Ab-2Anti-Human UTS2B monoclonal antibodyHuman
GM-Tg-rg-SE0540-Ab-1/ GM-Tg-rg-SE0540-Ab-2Anti-Rat UTS2B monoclonal antibodyRat
GM-Tg-mg-SE0540-Ab-1/ GM-Tg-mg-SE0540-Ab-2Anti-Mouse UTS2B monoclonal antibodyMouse
GM-Tg-cynog-SE0540-Ab-1/ GM-Tg-cynog-SE0540-Ab-2Anti-Cynomolgus/ Rhesus macaque UTS2B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0540-Ab-1/ GM-Tg-felg-SE0540-Ab-2Anti-Feline UTS2B monoclonal antibodyFeline
GM-Tg-cang-SE0540-Ab-1/ GM-Tg-cang-SE0540-Ab-2Anti-Canine UTS2B monoclonal antibodyCanine
GM-Tg-bovg-SE0540-Ab-1/ GM-Tg-bovg-SE0540-Ab-2Anti-Bovine UTS2B monoclonal antibodyBovine
GM-Tg-equg-SE0540-Ab-1/ GM-Tg-equg-SE0540-Ab-2Anti-Equine UTS2B monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0540-Ab-1/ GM-Tg-hg-SE0540-Ab-2; GM-Tg-rg-SE0540-Ab-1/ GM-Tg-rg-SE0540-Ab-2;
GM-Tg-mg-SE0540-Ab-1/ GM-Tg-mg-SE0540-Ab-2; GM-Tg-cynog-SE0540-Ab-1/ GM-Tg-cynog-SE0540-Ab-2;
GM-Tg-felg-SE0540-Ab-1/ GM-Tg-felg-SE0540-Ab-2; GM-Tg-cang-SE0540-Ab-1/ GM-Tg-cang-SE0540-Ab-2;
GM-Tg-bovg-SE0540-Ab-1/ GM-Tg-bovg-SE0540-Ab-2; GM-Tg-equg-SE0540-Ab-1/ GM-Tg-equg-SE0540-Ab-2
Products NameAnti-UTS2B monoclonal antibody
Formatmab
Target NameUTS2B
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-UTS2B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0540-Ag-1Recombinant multi-species UTS2B/ U2B/ URP protein


    Target information

    Target IDGM-SE0540
    Target NameUTS2B
    Gene ID257313,224065,378939,705342,608290,101080731,614653,100059874
    Gene Symbol and SynonymsGm538,U-IIB,U2B,UIIB,URP,UTS2B,UTS2D
    Uniprot AccessionQ765I0,Q765I2
    Uniprot Entry NameUTS2B_HUMAN,UTS2B_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000188958
    Target ClassificationN/A

    The target: UTS2B, gene name: UTS2B, also named as U2B, URP, UTS2D. Predicted to enable G protein-coupled receptor binding activity. Predicted to be involved in regulation of blood pressure. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.